180 related articles for article (PubMed ID: 20847058)
1. Genetic risk profiles identify different molecular etiologies for glioma.
Simon M; Hosking FJ; Marie Y; Gousias K; Boisselier B; Carpentier C; Schramm J; Mokhtari K; Hoang-Xuan K; Idbaih A; Delattre JY; Lathrop M; Robertson LB; Houlston RS; Sanson M
Clin Cancer Res; 2010 Nov; 16(21):5252-9. PubMed ID: 20847058
[TBL] [Abstract][Full Text] [Related]
2. Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies.
Di Stefano AL; Enciso-Mora V; Marie Y; Desestret V; Labussière M; Boisselier B; Mokhtari K; Idbaih A; Hoang-Xuan K; Delattre JY; Houlston RS; Sanson M
Neuro Oncol; 2013 May; 15(5):542-7. PubMed ID: 23161787
[TBL] [Abstract][Full Text] [Related]
3. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide association study identifies five susceptibility loci for glioma.
Shete S; Hosking FJ; Robertson LB; Dobbins SE; Sanson M; Malmer B; Simon M; Marie Y; Boisselier B; Delattre JY; Hoang-Xuan K; El Hallani S; Idbaih A; Zelenika D; Andersson U; Henriksson R; Bergenheim AT; Feychting M; Lönn S; Ahlbom A; Schramm J; Linnebank M; Hemminki K; Kumar R; Hepworth SJ; Price A; Armstrong G; Liu Y; Gu X; Yu R; Lau C; Schoemaker M; Muir K; Swerdlow A; Lathrop M; Bondy M; Houlston RS
Nat Genet; 2009 Aug; 41(8):899-904. PubMed ID: 19578367
[TBL] [Abstract][Full Text] [Related]
5. Interaction between 5 genetic variants and allergy in glioma risk.
Schoemaker MJ; Robertson L; Wigertz A; Jones ME; Hosking FJ; Feychting M; Lönn S; McKinney PA; Hepworth SJ; Muir KR; Auvinen A; Salminen T; Kiuru A; Johansen C; Houlston RS; Swerdlow AJ
Am J Epidemiol; 2010 Jun; 171(11):1165-73. PubMed ID: 20462933
[TBL] [Abstract][Full Text] [Related]
6. Genetic causes of glioma: new leads in the labyrinth.
Melin B
Curr Opin Oncol; 2011 Nov; 23(6):643-7. PubMed ID: 21825990
[TBL] [Abstract][Full Text] [Related]
7. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
[TBL] [Abstract][Full Text] [Related]
9. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
Wu Q; Peng Y; Zhao X
Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184
[TBL] [Abstract][Full Text] [Related]
10. Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.
Melin B; Dahlin AM; Andersson U; Wang Z; Henriksson R; Hallmans G; Bondy ML; Johansen C; Feychting M; Ahlbom A; Kitahara CM; Wang SS; Ruder AM; Carreón T; Butler MA; Inskip PD; Purdue M; Hsing AW; Mechanic L; Gillanders E; Yeager M; Linet M; Chanock SJ; Hartge P; Rajaraman P
Int J Cancer; 2013 May; 132(10):2464-8. PubMed ID: 23115063
[TBL] [Abstract][Full Text] [Related]
11. Genetic advances in glioma: susceptibility genes and networks.
Liu Y; Shete S; Hosking F; Robertson L; Houlston R; Bondy M
Curr Opin Genet Dev; 2010 Jun; 20(3):239-44. PubMed ID: 20211558
[TBL] [Abstract][Full Text] [Related]
12. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
Jenkins RB; Wrensch MR; Johnson D; Fridley BL; Decker PA; Xiao Y; Kollmeyer TM; Rynearson AL; Fink S; Rice T; McCoy LS; Halder C; Kosel ML; Giannini C; Tihan T; O'Neill BP; Lachance DH; Yang P; Wiemels J; Wiencke JK
Cancer Genet; 2011 Jan; 204(1):13-8. PubMed ID: 21356187
[TBL] [Abstract][Full Text] [Related]
13. New insights into susceptibility to glioma.
Liu Y; Shete S; Hosking FJ; Robertson LB; Bondy ML; Houlston RS
Arch Neurol; 2010 Mar; 67(3):275-8. PubMed ID: 20212223
[TBL] [Abstract][Full Text] [Related]
14. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population.
Chen H; Chen Y; Zhao Y; Fan W; Zhou K; Liu Y; Zhou L; Mao Y; Wei Q; Xu J; Lu D
Am J Epidemiol; 2011 Apr; 173(8):915-22. PubMed ID: 21350045
[TBL] [Abstract][Full Text] [Related]
15. Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis.
Wu Y; Zhou J; Zhang J; Tang Z; Chen X; Huang L; Liu S; Chen H; Wang Y
Front Oncol; 2023; 13():1180099. PubMed ID: 37746290
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study of glioma and meta-analysis.
Rajaraman P; Melin BS; Wang Z; McKean-Cowdin R; Michaud DS; Wang SS; Bondy M; Houlston R; Jenkins RB; Wrensch M; Yeager M; Ahlbom A; Albanes D; Andersson U; Freeman LE; Buring JE; Butler MA; Braganza M; Carreon T; Feychting M; Fleming SJ; Gapstur SM; Gaziano JM; Giles GG; Hallmans G; Henriksson R; Hoffman-Bolton J; Inskip PD; Johansen C; Kitahara CM; Lathrop M; Liu C; Le Marchand L; Linet MS; Lonn S; Peters U; Purdue MP; Rothman N; Ruder AM; Sanson M; Sesso HD; Severi G; Shu XO; Simon M; Stampfer M; Stevens VL; Visvanathan K; White E; Wolk A; Zeleniuch-Jacquotte A; Zheng W; Decker P; Enciso-Mora V; Fridley B; Gao YT; Kosel M; Lachance DH; Lau C; Rice T; Swerdlow A; Wiemels JL; Wiencke JK; Shete S; Xiang YB; Xiao Y; Hoover RN; Fraumeni JF; Chatterjee N; Hartge P; Chanock SJ
Hum Genet; 2012 Dec; 131(12):1877-88. PubMed ID: 22886559
[TBL] [Abstract][Full Text] [Related]
17. CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.
Adel Fahmideh M; Lavebratt C; Schüz J; Röösli M; Tynes T; Grotzer MA; Johansen C; Kuehni CE; Lannering B; Prochazka M; Schmidt LS; Feychting M
Carcinogenesis; 2015 Aug; 36(8):876-82. PubMed ID: 26014354
[TBL] [Abstract][Full Text] [Related]
18. Australian genome-wide association study confirms higher female risk for adult glioma associated with variants in the region of CCDC26.
Alpen K; Vajdic CM; MacInnis RJ; Milne RL; Koh ES; Hovey E; Harrup R; Bruinsma F; Nguyen TL; Li S; Joseph D; Benke G; Dugué PA; Southey MC; Giles GG; Rosenthal M; Drummond KJ; Nowak AK; Hopper JL; Kapuscinski M; Makalic E
Neuro Oncol; 2023 Jul; 25(7):1355-1365. PubMed ID: 36541697
[TBL] [Abstract][Full Text] [Related]
19. RTEL1 tagging SNPs and haplotypes were associated with glioma development.
Li G; Jin T; Liang H; Zhang Z; He S; Tu Y; Yang H; Geng T; Cui G; Chen C; Gao G
Diagn Pathol; 2013 May; 8():83. PubMed ID: 23683922
[TBL] [Abstract][Full Text] [Related]
20. Pleckstrin homology-like domain family B member 1 rs498872 polymorphism and glioma risk in Chinese Han population.
Zhang JW; Liu ZH; Lin XH; Du YP; Guo HT
Cell Mol Biol (Noisy-le-grand); 2017 Aug; 63(8):7-9. PubMed ID: 28886307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
